Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.
Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...
2d
News-Medical.Net on MSNA safer and more affordable polio vaccine could soon be a realityA more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.
Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.
Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).
University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...
His earliest memory is the day he left the polio treatment center for the final time. Of course, Addison’s weak left leg ...
Kennedy Jr.’s nomination for Secretary of Health and Human Services. McConnell — who credits advances in polio treatment with saving his life after he was stricken by disease as a toddler ...
Green, where he began physical therapy, a sometimes painful process. He approaches his stories on recovery from polio as a reporter, with descriptions, names, dates and quotes from other patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results